Bioavailability/Bioequivalence Site Evaluation During the Pandemic U.S. Food and Drug Administration 17:43 3 years ago 528 Далее Скачать
A New Possible Way to Evaluate Bioequivalence of Topical Drugs U.S. Food and Drug Administration 0:54 5 years ago 2 714 Далее Скачать
Data Integrity Issues in Bioequivalence Studies U.S. Food and Drug Administration 25:57 3 years ago 932 Далее Скачать
Developing and Implementing Science-Based Standards in Bioequivalence Assessment U.S. Food and Drug Administration 21:11 3 years ago 759 Далее Скачать
Addressing Common Challenges in BE Studies Due to COVID-19: OGD’s Approach U.S. Food and Drug Administration 21:19 3 years ago 295 Далее Скачать
COVID-19 Impact on Generic Drug Regulation and Evaluation U.S. Food and Drug Administration 1:48:13 3 years ago 1 259 Далее Скачать
Using Generics and Understanding Bioequivalence HealthOutcomesStrats 4:17 11 years ago 12 915 Далее Скачать
Common Deficiencies for Study Sample Reanalysis in PK BE for ANDAs - Bioanalysis 2020 U.S. Food and Drug Administration 17:53 4 years ago 1 420 Далее Скачать
Case Study: Bioanalytical Approaches to Mitigate Issues during a BE Inspection - Bioanalysis 2020 U.S. Food and Drug Administration 26:11 4 years ago 873 Далее Скачать
Best Practices for Conducting Bioequivalence Studies (16of27) Generic Drugs Forum 2018 U.S. Food and Drug Administration 30:26 4 years ago 3 646 Далее Скачать
Assessment during the COVID-19 Pandemic: Ethical, Legal, & Safety. Stifel et al. 2020 School Psychology Review 2:00 3 years ago 412 Далее Скачать
Review of Clinical Endpoint Bioequivalence Studies in ANDAs (17/28) Generic Drugs Forum 2017 U.S. Food and Drug Administration 19:20 4 years ago 1 572 Далее Скачать
Is Cost Effectiveness Analysis Useful for Addressing the Pandemic? Belfer Center 0:51 3 years ago 347 Далее Скачать
Best Practices for Topical Generic Product Development & ANDA Submission–Session 3, Closing Remarks U.S. Food and Drug Administration 58:05 2 years ago 696 Далее Скачать
Evaluation of the organizational resilience of UNFPA in light of its response to COVID-19 pandemic UNFPA Independent Evaluation Office 2:15 4 months ago 283 Далее Скачать
OSI’s Role in the Drug Development Process and Impact of COVID-19 U.S. Food and Drug Administration 54:02 3 years ago 1 915 Далее Скачать
Interview with Janet Woodcock | FDA Center for Drug Evaluation EM:RAP Medical Education 18:56 4 years ago 1 053 Далее Скачать
Bioavailability-Bioequivalence. First Day Part 1 ΕΚΠΑ ΝΚUA 2:01:56 Streamed 1 year ago 59 Далее Скачать
Rapid Qualitative Multi-Method Assessment of the Impacts of the COVID-19 Pandemic... Planetary Health Alliance 4:14 1 year ago 8 Далее Скачать
Bioavailability-Bioequivalence: From classification to virtualization and anything in between ΕΚΠΑ ΝΚUA 1:12:39 Streamed 1 year ago 69 Далее Скачать